<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moshomo T</submitter><funding>United States of America National Institute of Health</funding><funding>NIMH NIH HHS</funding><funding>United States of America National Institute of Health (NIH)</funding><funding>NHLBI NIH HHS</funding><pagination>80</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11264446</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Successful HIV treatment programs have turned HIV into a chronic condition, but noncommunicable diseases such as hypertension jeopardize this progress. Hypertension control rates among people with HIV (PWH) are low owing to gaps in patient awareness, diagnosis, effective treatment, and management of both conditions at separate clinic visits. Integrated management, such as in our study, InterCARE, can enhance HIV-hypertension integration and blood pressure (BP) control.&lt;h4>Methods&lt;/h4>Our pilot study was conducted in two Botswana HIV clinics between October 2021 and November 2022. Based on our formative work, we adopted three main strategies; Health worker training on HTN/cardiovascular disease (CVD) management, adaptation of HIV Electronic Health Record (EHR) for HTN/CVD</pubmed_abstract><journal>Implementation science communications</journal><pubmed_title>Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in Botswana.</pubmed_title><pmcid>PMC11264446</pmcid><funding_grant_id>UG3 HL154499</funding_grant_id><funding_grant_id>UG3HL 154499</funding_grant_id><funding_grant_id>P30 MH058107</funding_grant_id><pubmed_authors>Van Pelt AE</pubmed_authors><pubmed_authors>Ilias M</pubmed_authors><pubmed_authors>Moshomo T</pubmed_authors><pubmed_authors>Molefe-Baikai OJ</pubmed_authors><pubmed_authors>Tonwe V</pubmed_authors><pubmed_authors>Gala P</pubmed_authors><pubmed_authors>Bennett K</pubmed_authors><pubmed_authors>Hurwitz KW</pubmed_authors><pubmed_authors>Mosepele M</pubmed_authors><pubmed_authors>Ponatshego P</pubmed_authors><pubmed_authors>Gaolathe T</pubmed_authors><pubmed_authors>Bogart LM</pubmed_authors><pubmed_authors>Hirschhorn LR</pubmed_authors><pubmed_authors>Youssouf N</pubmed_authors><pubmed_authors>Dintwa E</pubmed_authors><pubmed_authors>Jaffar S</pubmed_authors><pubmed_authors>Ramotsababa M</pubmed_authors><pubmed_authors>Seipone K</pubmed_authors><pubmed_authors>Mogaetsho E</pubmed_authors><pubmed_authors>Kebotsamang K</pubmed_authors><pubmed_authors>Steger-May K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in Botswana.</name><description>&lt;h4>Background&lt;/h4>Successful HIV treatment programs have turned HIV into a chronic condition, but noncommunicable diseases such as hypertension jeopardize this progress. Hypertension control rates among people with HIV (PWH) are low owing to gaps in patient awareness, diagnosis, effective treatment, and management of both conditions at separate clinic visits. Integrated management, such as in our study, InterCARE, can enhance HIV-hypertension integration and blood pressure (BP) control.&lt;h4>Methods&lt;/h4>Our pilot study was conducted in two Botswana HIV clinics between October 2021 and November 2022. Based on our formative work, we adopted three main strategies; Health worker training on HTN/cardiovascular disease (CVD) management, adaptation of HIV Electronic Health Record (EHR) for HTN/CVD</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-05-22T03:19:57.944Z</modification><creation>2025-06-01T01:15:46.987Z</creation></dates><accession>S-EPMC11264446</accession><cross_references><pubmed>39039609</pubmed><doi>10.1186/s43058-024-00620-w</doi></cross_references></HashMap>